Literature DB >> 1555372

Percutaneous catheter drainage of amoebic liver abscess.

V A Saraswat1, D K Agarwal, S S Baijal, S Roy, G Choudhuri, R K Dhiman, L Bhandari, S R Naik.   

Abstract

Fifteen patients with amoebic liver abscesses underwent percutaneous catheter drainage under ultrasonographic guidance. Thirteen patients had solitary abscesses (right lobe 12, left lobe 1), two had associated subdiaphragmatic collections, while two patients had multiple abscesses. The indications for the drainage included lack of response to medical therapy: imminent rupture in five cases; ruptured liver abscesses in three; enlarging abscesses after hospitalization in three; persistent symptoms in two; and large left lobe abscesses in two. The volume of the abscesses before drainage was 102-1008 ml (mean 432 ml). Pigtail catheters (8 F) were used in nine of the patients and 12 F sump catheters in six. When multiple abscesses and associated subdiaphragmatic collection were present, each was drained separately. The catheters were removed (mean 7 days, range 3-20 days) when patients became apyrexial, catheter drainage was less than 10 ml in 24 h and cavitogram showed a negligible cavity (mean residual volume 5.5 ml, range 3-15 ml). Complications included minor blood loss through the catheter for 12 h in one patient and reappearance of the abscess in another requiring further drainage. Our experience suggests that catheter drainage of amoebic liver abscesses in selected cases is safe and effective, and results in prompt and early resolution of the abscess cavity with restoration of normal parenchyma.

Entities:  

Mesh:

Year:  1992        PMID: 1555372     DOI: 10.1016/s0009-9260(05)80639-7

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  13 in total

1.  Complications of percutaneous fluid drainage.

Authors:  Jonathan Lorenz; Jamie Lee Thomas
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

Review 2.  Percutaneous needle aspiration versus catheter drainage in the management of liver abscess: a systematic review and meta-analysis.

Authors:  Yu-Long Cai; Xian-Ze Xiong; Jiong Lu; Yao Cheng; Chen Yang; Yi-Xin Lin; Jie Zhang; Nan-Sheng Cheng
Journal:  HPB (Oxford)       Date:  2014-09-10       Impact factor: 3.647

3.  Experience with aspiration in cases of amebic liver abscess in an endemic area.

Authors:  S Khanna; D Chaudhary; A Kumar; J C Vij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

4.  Amoebiasis: a rare cause of cardiac tamponade.

Authors:  L N Gomersall; J Currie; R Jeffrey
Journal:  Br Heart J       Date:  1994-04

5.  Identification of high-risk group and therapeutic options in children with liver abscess.

Authors:  Anshu Srivastava; Surender Kumar Yachha; Vikas Arora; Ujjal Poddar; Richa Lal; Sanjay S Baijal
Journal:  Eur J Pediatr       Date:  2011-05-03       Impact factor: 3.183

6.  Analysis of 69 patients with amebic liver abscess.

Authors:  K C Lee; O Yamazaki; H Hamba; Y Sakaue; H Kinoshita; K Hirohashi; S Kubo
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

7.  Comparative study of catheter drainage and needle aspiration in management of large liver abscesses.

Authors:  Onkar Singh; Shilpi Gupta; Sonia Moses; Devendra K Jain
Journal:  Indian J Gastroenterol       Date:  2009-11-12

Review 8.  Amebic infection in humans.

Authors:  Gourdas Choudhuri; Murali Rangan
Journal:  Indian J Gastroenterol       Date:  2012-08-19

9.  What affects mortality after the operative management of hepatic abscess?

Authors:  John D Christein; Michael L Kendrick; Florencia G Que
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

10.  Prognostic indications of the failure to treat amoebic liver abscesses.

Authors:  Martín Sánchez-Aguilar; Onofre Morán-Mendoza; Miguel F Herrera-Hernández; Juan Francisco Hernández-Sierra; Peter B Mandeville; J Humberto Tapia-Pérez; Martín Sánchez-Reyna; José Juan Sánchez-Rodríguez; Antonio Gordillo-Moscoso
Journal:  Pathog Glob Health       Date:  2012-08       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.